Momentum Stocks Hit A Wall… And Gilead’s Shot To The Arm 6/20/24
CNBC's "Fast Money"
00:00
Stock Market Updates and Pharmaceutical Industry Analysis
The chapter covers Gilead's stock market success following positive data on its HIV prevention injection and discusses the company's pivot towards oncology. It delves into the search for the next player in the pharmaceutical market and the potential growth drivers for companies like Eli Lilly. Additionally, it explores the impact of FDA approvals on stock prices, the influence of heat waves on utility companies, and regulatory issues in the energy sector.
Play episode from 29:58
Transcript
